Zdrowie i gospodarka · 10/02/2015

FDA Releases Draft Guidance for Individual Patient Expanded Access Applications

The Food and Drug Administration (FDA) has made available a draft guidance for industry on Individual Patient Expanded Access Applications, which outlines the process for submitting an Investigational New Drug Application (IND) for use in expanded access cases, and invites public comment on the draft document.